bêta
IA Trial Radar

Voici les essais cliniques pour Diabète filtrés pour le lieu : North Carolina.

Je peux vous aider à comprendre votre état de santé, les traitements ou à trouver des essais cliniques près de chez vous.
Notre outil de recherche ne prend en charge que l'anglais. Pour la recherche et la discussion dans d'autres langues, utilisez l'IA Trial Radar ci-dessus ou sélectionnez les filtres de condition médicale et de lieu ci-dessous.
24 résultats trouvés
 
Pathologie
Diabète
×
 
Mots clés
Surveillance continue du glucose
×
 
Lieux
North Carolina
×
 
Sexe
Tous
×
 
Titre de l'étude
Statut
Examining The Role of CGM in T2DM NCT01614262
Terminé
CGM for Management of Type 2 Diabetes in Pregnancy (CGM2) NCT06628453
En recrutement
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control NCT00806520
Terminé
A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas NCT02092220
TerminéRésultats publiés
Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia NCT04521712
Terminé
Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) NCT03566693
Terminé
Time in Glucose Hospital Target (TIGHT) NCT05135676
Terminé
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D) (CITY) NCT03263494
Terminé
Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes NCT03650088
TerminéRésultats publiés
Integrating New Skills Into Diabetes Education With CGM (INSIDE-CGM) NCT07463209
Pas encore en recrutement
Mindfulness: a Novel Approach for the Management of Diabetes-related Distress NCT01805245
Terminé
Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes (MIPOD) NCT00835861
TerminéRésultats publiés
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes NCT05904743
Terminé
OP5-005 Using Omnipod 5 in Adults With Type 2 (SECURE-T2D) NCT05815342
TerminéRésultats publiés
NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations (NCW4H) NCT04815278
Terminé
A Study of CT-868 in Type 1 Diabetes Mellitus NCT06062069
Terminé
Baseline Oral Health Study: UnCoVer the Connections to General Health NCT04954313
TerminéRésultats publiés
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) NCT03240432
Terminé
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 1) NCT04460885
TerminéRésultats publiés
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) NCT06297603
Actif, ne recrute pas
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes (SAFEGUARD) NCT07187531
En recrutement
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes NCT01243424
TerminéRésultats publiés
Fenofibrate for Prevention of DR Worsening (Protocol AF) NCT04661358
En recrutement
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor (REIMAGINE 2) NCT06065540
Terminé